T1	Participants 65 101	patients undergoing cholecystectomy.
T2	Participants 423 462	24 patients undergoing cholecystectomy.
T3	Participants 463 475	Ten patients
T4	Participants 602 619	The placebo group
T5	Participants 912 920	patients
T6	Participants 1480 1508	cholecystectomized patients.
